✦ LIBER ✦

1070 Phase II trial with docetaxel in patients (PTS) with non small cell lung cancer (NSCLC)

✍ Scribed by Latreille, J.; Laberge, F.; Viallet, J.; Maksymiuk, A.; Shepherd, F.; Gelmon, K.; Delorme, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I–II study of docetaxel (D) and

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Late phase II trial of RP 56976 (docetax

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Phase I/II trial of gemcitabine plus doc

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

Phase II trial of weekly docetaxel (D) i

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A multicenter phase II trial with gemcit

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

37 Docetaxel and cisplatin combination i

✍ Belani, C.P.; Bonomi, P.; Dobbs, T.; DeVore, R.; Ettinger, D.; Jett, J.; Kozak, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 301 KB